Clinical Trial Update: A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Zanzalintinib in recurrent or progressive meningioma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• Zanzalintinib (Zanzalintinib)

Snippet

Sponsor: Exelixis | Conditions: Meningioma | Phase 2 | Status: NOT_YET_RECRUITING